News

Under the terms of the collaboration, Galapagos will receive an upfront payment of $400,000 and may receive research funding to support Bausch & Lomb’s further development of the

The study showed that a single vaccination of Imvamune could protect a variety of immune suppressed animals on the same day as a lethal challenge with Ectromelia virus;

PPA Technologies is developing a technical solution for active support in cases of cardiac insufficiency and complete temporary support during cardiac arrest. This technology could be complementary to

Under the terms of the agreement, HP will manage Nycomed’s data centers, including more than 450 servers and 120 terabytes (TB) of storage and back-up facilities. HP will

Mr Kolker most recently held the position of group vice president and corporate controller in both the company and Taro USA, and also served as the company’s interim

The study was conducted on 16 rabbits that underwent open gynaecologic surgery in a uterine horn model. In preclinical testing, company’s fibrin sealant was found to be significantly

In the study, patients were dosed once a day for up to six months with either a 6mg IoGen tablet or placebo. There was no statistically significant difference

Joseph Mollica, chairman of the board, will assume day-to-day leadership responsibilities on an interim basis until a successor is appointed. A search will be undertaken to identify a

BSI-201, the first poly ADP-ribose polymerase (PARP) inhibitor in BiPar’s DNA repair portfolio, crosses the blood-brain barrier, a unique property that enables its targeted investigation in the brain